OnKure Therapeutics (OKUR) Other financing activities (2020 - 2024)
OnKure Therapeutics' (OKUR) quarterly Other financing activities came in at $1000.0 in Q4 2024, up 100.26% YoY from $499.36 in Q1 2024, and down 80.0% on a QoQ basis from $5000.0 in Q3 2024.
OnKure Therapeutics (OKUR) Other financing activities (2020 - 2024) Analysis & Trends
OnKure Therapeutics (OKUR) has 5 years of Other financing activities data on file, last reported at $1000.0 in Q4 2024.
- Quarterly Other financing activities rose 100.26% year-over-year to $1000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $26000.0 (up 100.58% YoY) and the FY2025 annual result came in at $240000.0, up 823.08% from the prior year.
- Other financing activities slipped to $1000.0 in Q4 2024, from $5000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $84.5 million in Q2 2021 to a low of -$4.2 million in Q3 2023.
- A 5-year average of $5.4 million and a median of $10000.0 in 2020 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities surged 4750.0% — and 2023, when it plunged 4442.27%.
- Tracing OKUR's Other financing activities over 5 years: stood at $10000.0 in 2020, then tumbled by 390.0% to -$29000.0 in 2021, then soared by 262.07% to $47000.0 in 2022, then slumped by 929.79% to -$390000.0 in 2023, then jumped by 100.26% to $1000.0 in 2024.
- The last three Other financing activities figures came in at $1000.0 (Q4 2024), $5000.0 (Q3 2024), and $10000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | OnKure Therapeutics | 196.98 Mn | 20.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Dec 31, 2023 | -390,000.00 |
| Dec 31, 2023 | -390,000.00 |
| Sep 30, 2023 | -4.21 Mn |
| Sep 30, 2023 | -4.21 Mn |
| Dec 31, 2022 | 47,000.00 |
| Dec 31, 2022 | 47,000.00 |
| Sep 30, 2022 | 97,000.00 |
| Sep 30, 2022 | 97,000.00 |
| Dec 31, 2021 | -29,000.00 |
| Dec 31, 2021 | -29,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |